{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:01:25Z","timestamp":1782802885587,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan","doi-asserted-by":"crossref","award":["232300421115"],"award-info":[{"award-number":["232300421115"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Project of Technology Innovation Leading Talent in Central Plain","award":["234200510003"],"award-info":[{"award-number":["234200510003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U23A20270"],"award-info":[{"award-number":["U23A20270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87941-5","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:42:12Z","timestamp":1738186932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Optimization of the intron sequences combined with the CMV promoter increases recombinant protein expression in CHO cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Ting-Ting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Liu","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Lei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"87941_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-020-2168-1","volume":"580","author":"RJ Deshaies","year":"2020","unstructured":"Deshaies, R. J. Multispecific drugs herald a new era of biopharmaceutical innovation. Nature 580, 329\u2013338 (2020).","journal-title":"Nature"},{"key":"87941_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","volume":"37","author":"AL Grilo","year":"2019","unstructured":"Grilo, A. L. & Mantalaris, A. The increasingly human and profitable monoclonal antibody market. Trends Biotechnol. 37, 9\u201316 (2019).","journal-title":"Trends Biotechnol."},{"key":"87941_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jbiotec.2023.05.001","volume":"369","author":"L Grindes","year":"2023","unstructured":"Grindes, L. et al. Weak promoters to drive selection marker expression: improvement of cell line development process for therapeutic protein production in CHO-K1 cells. J. Biotechnol. 369, 43\u201354 (2023).","journal-title":"J. Biotechnol."},{"key":"87941_CR4","doi-asserted-by":"publisher","first-page":"e1700227","DOI":"10.1002\/biot.201700227","volume":"13","author":"G Stolfa","year":"2018","unstructured":"Stolfa, G. et al. CHO-omics review: the impact of current and emerging technologies on Chinese Hamster ovary based Bioproduction. Biotechnol. J. 13, e1700227 (2018).","journal-title":"Biotechnol. J."},{"key":"87941_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","volume":"36","author":"J Dumont","year":"2016","unstructured":"Dumont, J., Euwart, D., Mei, B., Estes, S. & Kshirsagar, R. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit. Rev. Biotechnol. 36, 1110\u20131122 (2016).","journal-title":"Crit. Rev. Biotechnol."},{"key":"87941_CR6","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1007\/s11033-020-05593-2","volume":"47","author":"DD Yi","year":"2020","unstructured":"Yi, D. D. et al. Construction of an expression vector mediated by the dual promoter for prokaryotic and mammalian cell expression system. Mol. Biol. Rep. 47, 5185\u20135190 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"87941_CR7","doi-asserted-by":"crossref","unstructured":"Wells, E. & Robinson, A. S. Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement. Biotechnol. J. 12 (2017).","DOI":"10.1002\/biot.201600105"},{"key":"87941_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","volume":"40","author":"G Walsh","year":"2022","unstructured":"Walsh, G. & Walsh, E. Biopharmaceutical benchmarks 2022. Nat. Biotechnol. 40, 1722\u20131760 (2022).","journal-title":"Nat. Biotechnol."},{"key":"87941_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1080\/07388551.2020.1805401","volume":"40","author":"X Guo","year":"2020","unstructured":"Guo, X., Wang, C. & Wang, T. Y. Chromatin-modifying elements for recombinant protein production in mammalian cell systems. Crit. Rev. Biotechnol. 40, 1035\u20131043 (2020).","journal-title":"Crit. Rev. Biotechnol."},{"key":"87941_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrc.2021.10.018","volume":"581","author":"S Katayama","year":"2021","unstructured":"Katayama, S. & Andou, M. Editing of DNA methylation using CRISPR\/Cas9 and a ssDNA template in human cells. Biochem. Biophys. Res. Commun. 581, 20\u201324 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"87941_CR11","doi-asserted-by":"publisher","first-page":"e2200638","DOI":"10.1002\/biot.202200638","volume":"18","author":"Y Shibafuji","year":"2023","unstructured":"Shibafuji, Y., Nagao, N. & Yohda, M. Cystine and tyrosine feed reduces oxidative and ER stress in CHO cells. Biotechnol. J. 18, e2200638 (2023).","journal-title":"Biotechnol. J."},{"key":"87941_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/elsc.202100062","volume":"22","author":"J Schellenberg","year":"2022","unstructured":"Schellenberg, J. et al. Stress-induced increase of monoclonal antibody production in CHO cells. Eng. Life Sci. 22, 427\u2013436 (2022).","journal-title":"Eng. Life Sci."},{"key":"87941_CR13","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/bit.23167","volume":"108","author":"M Matasci","year":"2011","unstructured":"Matasci, M., Baldi, L., Hacker, D. L. & Wurm, F. M. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability. Biotechnol. Bioeng. 108, 2141\u20132150 (2011).","journal-title":"Biotechnol. Bioeng."},{"key":"87941_CR14","first-page":"18","volume":"49","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Effects of different promoters and MAR combinations on transgene expression of recombinant CHO cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 49, 18\u201323 (2018).","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"87941_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ymben.2021.04.014","volume":"66","author":"N Marx","year":"2021","unstructured":"Marx, N. et al. Enhanced targeted DNA methylation of the CMV and endogenous promoters with dCas9-DNMT3A3L entails distinct subsequent histone modification changes in CHO cells. Metab. Eng. 66, 268\u2013282 (2021).","journal-title":"Metab. Eng."},{"key":"87941_CR16","doi-asserted-by":"publisher","first-page":"722722","DOI":"10.3389\/fbioe.2022.722722","volume":"10","author":"XY Wang","year":"2022","unstructured":"Wang, X. Y. et al. Enhanced transgene expression by optimization of poly A in transfected CHO cells. Front. Bioeng. Biotechnol. 10, 722722 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"87941_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/10826068.2021.1963981","volume":"52","author":"CC Doan","year":"2022","unstructured":"Doan, C. C. et al. Enhancement of anti-TNF\u03b1 monoclonal antibody production in CHO cells through the use of UCOE and DHFR elements in vector construction and the optimization of cell culture media. Prep. Biochem. Biotechnol. 52, 452\u2013470 (2022).","journal-title":"Prep. Biochem. Biotechnol."},{"key":"87941_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbiotec.2020.09.006","volume":"324","author":"R Hoseinpoor","year":"2020","unstructured":"Hoseinpoor, R., Kazemi, B., Rajabibazl, M. & Rahimpour, A. Improving the expression of anti-IL-2R\u03b1 monoclonal antibody in the CHO cells through optimization of the expression vector and translation efficiency. J. Biotechnol. 324, 112\u2013120 (2020).","journal-title":"J. Biotechnol."},{"key":"87941_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.csbj.2022.11.059","volume":"21","author":"RE Sizer","year":"2023","unstructured":"Sizer, R. E. & White, R. J. Use of ubiquitous chromatin opening elements (UCOE) as tools to maintain transgene expression in biotechnology. Comput. Struct. Biotechnol. J. 21, 275\u2013283 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"87941_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/biot.201400744","volume":"10","author":"AJ Brown","year":"2015","unstructured":"Brown, A. J., Sweeney, B., Mainwaring, D. O. & James, D. C. NF-\u03baB, CRE and YY1 elements are key functional regulators of CMV promoter-driven transient gene expression in CHO cells. Biotechnol. J. 10, 1019\u20131028 (2015).","journal-title":"Biotechnol. J."},{"key":"87941_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jbiotec.2016.10.005","volume":"239","author":"R Rom\u00e1n","year":"2016","unstructured":"Rom\u00e1n, R. et al. Enhancing heterologous protein expression and secretion in HEK293 cells by means of combination of CMV promoter and IFN\u03b12 signal peptide. J. Biotechnol. 239, 57\u201360 (2016).","journal-title":"J. Biotechnol."},{"key":"87941_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/2211-5463.13029","volume":"11","author":"Y Dou","year":"2021","unstructured":"Dou, Y. et al. The CAG promoter maintains high-level transgene expression in HEK293 cells. FEBS Open. Bio. 11, 95\u2013104 (2021).","journal-title":"FEBS Open. Bio"},{"key":"87941_CR23","doi-asserted-by":"publisher","first-page":"e1700232","DOI":"10.1002\/biot.201700232","volume":"13","author":"N Romanova","year":"2018","unstructured":"Romanova, N. & Noll, T. Engineered and Natural promoters and chromatin-modifying elements for recombinant protein expression in CHO cells. Biotechnol. J. 13, e1700232 (2018).","journal-title":"Biotechnol. J."},{"key":"87941_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pep.2009.08.010","volume":"69","author":"SC Mariati, Ho","year":"2010","unstructured":"Mariati, Ho, S. C., Yap, M. G. & Yang, Y. Evaluating post-transcriptional regulatory elements for enhancing transient gene expression levels in CHO K1 and HEK293 cells. Protein Expr. Purif. 69, 9\u201315 (2010).","journal-title":"Protein Expr. Purif."},{"key":"87941_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/btpr.2271","volume":"32","author":"B Moritz","year":"2016","unstructured":"Moritz, B., Woltering, L., Becker, P. B. & G\u00f6pfert, U. High levels of histone H3 acetylation at the CMV promoter are predictive of stable expression in Chinese hamster ovary cells. Biotechnol. Prog. 32, 776\u2013786 (2016).","journal-title":"Biotechnol. Prog."},{"key":"87941_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12033-017-0019-6","volume":"59","author":"BPC Soo","year":"2017","unstructured":"Soo, B. P. C. et al. Correlation between expression of recombinant proteins and abundance of H3K4Me3 on the enhancer of human cytomegalovirus major immediate-early promoter. Mol. Biotechnol. 59, 315\u2013322 (2017).","journal-title":"Mol. Biotechnol."},{"key":"87941_CR27","doi-asserted-by":"publisher","first-page":"105570","DOI":"10.1016\/j.pep.2020.105570","volume":"168","author":"U Rojas-S\u00e1nchez","year":"2020","unstructured":"Rojas-S\u00e1nchez, U., L\u00f3pez-Calleja, A. C., Mill\u00e1n-Chiu, B. E., Fern\u00e1ndez, F. & Loske, A. M., G\u00f3mez-Lim, M. A. enhancing the yield of human erythropoietin in Aspergillus Niger by introns and CRISPR-Cas9. Protein Expr. Purif. 168, 105570 (2020).","journal-title":"Protein Expr Purif."},{"key":"87941_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biocel.2017.06.016","volume":"91","author":"O Shaul","year":"2017","unstructured":"Shaul, O. How introns enhance gene expression. Int. J. Biochem. Cell. Biol. 91, 145\u2013155 (2017).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"87941_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00294-017-0802-8","volume":"64","author":"SK Mishra","year":"2018","unstructured":"Mishra, S. K. & Thakran, P. Intron specificity in pre-mRNA splicing. Curr. Genet. 64, 777\u2013784 (2018).","journal-title":"Curr. Genet."},{"key":"87941_CR30","first-page":"1267","volume":"116","author":"X Li","year":"2003","unstructured":"Li, X., Zhong, F. & Qi, S. Modification of pGH cDNA using the first intron and adenovirus-mediated expression in CHO cells. Chin. Med. J. (Engl.). 116, 1267\u20131269 (2003).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"87941_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10529-012-1043-z","volume":"35","author":"LS Quilici","year":"2013","unstructured":"Quilici, L. S. et al. A minimal cytomegalovirus intron a variant can improve transgene expression in different mammalian cell lines. Biotechnol. Lett. 35, 21\u201327 (2013).","journal-title":"Biotechnol. Lett."},{"key":"87941_CR32","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.4049\/jimmunol.1502687","volume":"196","author":"JM Colston","year":"2016","unstructured":"Colston, J. M., Bolinger, B., Cottingham, M. G., Gilbert, S. & Klenerman, P. Modification of antigen impacts on memory quality after adenovirus vaccination. J. Immunol. 196, 3354\u20133363 (2016).","journal-title":"J. Immunol."},{"key":"87941_CR33","doi-asserted-by":"publisher","first-page":"15396","DOI":"10.1038\/s41598-018-33500-0","volume":"8","author":"CP Lee","year":"2018","unstructured":"Lee, C. P. et al. Regulatory elements in vectors containing the ctEF-1\u03b1 first intron and double enhancers for an efficient recombinant protein expression system. Sci. Rep. 8, 15396 (2018).","journal-title":"Sci. Rep."},{"key":"87941_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0168-1656(01)00388-1","volume":"93","author":"SY Kim","year":"2002","unstructured":"Kim, S. Y., Lee, J. H., Shin, H. S., Kang, H. J. & Kim, Y. S. The human elongation factor 1 alpha (EF-1 alpha) first intron highly enhances expression of foreign genes from the murine cytomegalovirus promoter. J. Biotechnol. 93, 183\u2013187 (2002).","journal-title":"J. Biotechnol."},{"key":"87941_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jviromet.2004.08.005","volume":"122","author":"S Hermening","year":"2004","unstructured":"Hermening, S., K\u00fcgler, S., B\u00e4hr, M. & Isenmann, S. Increased protein expression from adenoviral shuttle plasmids and vectors by insertion of a small chimeric intron sequence. J. Virol. Methods. 122, 73\u201377 (2004).","journal-title":"J. Virol. Methods"},{"key":"87941_CR36","first-page":"1071","volume":"35","author":"W Dong","year":"2019","unstructured":"Dong, W., Li, C., Yang, Y., Wang, T. & Wang, F. Increasing transgenic expression in recombinant Chinese hamster ovary cells using introns in different directions. Sheng Wu Gong. Cheng Xue Bao. 35, 1071\u20131078 (2019).","journal-title":"Sheng Wu Gong. Cheng Xue Bao"},{"key":"87941_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11033-019-05153-3","volume":"47","author":"YM Li","year":"2020","unstructured":"Li, Y. M. et al. Effects of different 2A peptides on transgene expression mediated by tricistronic vectors in transfected CHO cells. Mol. Biol. Rep. 47, 469\u2013475 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"87941_CR38","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1021\/acssynbio.0c00310","volume":"9","author":"CKC Lam","year":"2020","unstructured":"Lam, C. K. C. & Truong, K. Engineering a synthesis-friendly constitutive promoter for mammalian cell expression. ACS Synth. Biol. 9, 2625\u20132631 (2020).","journal-title":"ACS Synth. Biol."},{"key":"87941_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12033-008-9055-6","volume":"39","author":"M Campos-da-Paz","year":"2008","unstructured":"Campos-da-Paz, M. et al. Production of recombinant human factor VIII in different cell lines and the effect of human XBP1 co-expression. Mol. Biotechnol. 39, 155\u2013158 (2008).","journal-title":"Mol. Biotechnol."},{"key":"87941_CR40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1073\/pnas.88.2.478","volume":"88","author":"RD Palmiter","year":"1991","unstructured":"Palmiter, R. D., Sandgren, E. P., Avarbock, M. R., Allen, D. D. & Brinster, R. L. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. U S A. 88, 478\u2013482 (1991).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"87941_CR41","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1111\/jcmm.13504","volume":"22","author":"DH Xu","year":"2018","unstructured":"Xu, D. H. et al. SV40 intron, a potent strong intron element that effectively increases transgene expression in transfected Chinese hamster ovary cells. J. Cell. Mol. Med. 22 (4), 2231\u20132239. https:\/\/doi.org\/10.1111\/jcmm.13504 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"87941_CR42","doi-asserted-by":"publisher","first-page":"166166","DOI":"10.1016\/j.bbadis.2021.166166","volume":"1867","author":"D Roos","year":"2021","unstructured":"Roos, D. & de Boer, M. Mutations in cis that affect mRNA synthesis, processing and translation. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166166 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"87941_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/bp049780w","volume":"21","author":"S Schlatter","year":"2005","unstructured":"Schlatter, S. et al. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol. Prog. 21, 122\u2013133 (2005).","journal-title":"Biotechnol. Prog."},{"key":"87941_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1570163817666200312102137","volume":"18","author":"SM Sharker","year":"2021","unstructured":"Sharker, S. M. & Rahman, A. A review on the current methods of Chinese Hamster ovary (CHO) cells cultivation for the production of therapeutic protein. Curr. Drug Discov. Technol. 18, 354\u2013364 (2021).","journal-title":"Curr. Drug Discov. Technol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87941-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87941-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:44:27Z","timestamp":1738187067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87941-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87941"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87941-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3732"}}